Outsourced Pharma Products & Services
-
Contract Manufacturing for Single Use Finished Medical Devices
3/2/2015
Passion for technology has driven SMC Ltd. to be a leading manufacturing partner to the top medical device OEMs. With operations spanning the United States, Costa Rica, and India, SMC is positioned to assist you on your next finished medical device.
-
Wrap-Around Pharmaceutical Labeler: HERMA 132M HC
12/11/2024
The 132M HC sets the standard for performance, precision, and reliability. This wrap-around labeler applies labels to cylindrical products with the utmost accuracy at the highest performance.
-
TARGATT™ iPSC Kits
9/30/2025
Build cell-based models of disease and accelerate therapeutic development with TARGATT™ large knock-in technology in iPSCs.
-
Oral Solid Dosage Development And Manufacturing
The Pharma Expanse network currently spans across 9 manufacturing sites in 5 countries and can support discovery, preclinical, clinical and commercial programs for New Chemical Entities (NCEs). Pharma Expanse has an innovative business model that does not add additional costs to your project. Review our network's drug product capabilities below and contact us to simplify your outsourcing solutions.
-
Contract Packaging: Stick-Pack Uni-Dose Packing
3/29/2012
Stick-pack uni-dose packing, globally accepted for its accuracy, convenience and cost-savings, is now available in North America from Ropack. A 15,000-square-foot Class 100000 dedicated facility ensures a controlled production environment for your contract packaging needs.
-
Analytical Method Development And Validation
7/29/2024
In pharmaceutical testing, the development and validation of analytical methods are absolute musts when it comes to reliable quality control. Natoli Scientific is at the forefront of offering comprehensive analytical method development and validation services designed to ensure the integrity of your company’s drug formulations. Our expert team develops robust methods tailored for each unique compound, with an approach that emphasizes precision, accuracy, sustainability, and compliance with regulatory standards such as the FDA and ICH guidelines. These methods are meticulously validated to confirm their reliability across a range of analytical parameters including specificity, sensitivity, linearity, and reproducibility.
This validation process is critical for verifying that our methods produce consistent, trustworthy results throughout the product’s lifecycle, thus fostering confidence in the safety and efficacy of pharmaceutical products.
-
iPSC Lines: iPSC Control Lines From Healthy Donors
9/30/2025
At Applied StemCell, we specialize in providing high-quality induced Pluripotent Stem Cell (iPSC) lines that are crucial for advanced research in stem cell biology and regenerative medicine. Our iPSC lines are designed to support cutting-edge research and therapeutic development.
-
Chromatography Systems
ÄKTA™ chromatography systems can handle both simple and complex purification tasks and accelerate daily routines. All systems are controlled by UNICORN™ software, a common control platform and user interface for all scales of operation.
-
Packaging And Analytical Laboratory Services
8/3/2020
PCI offers in-house laboratories providing a range of packaging and analytical laboratory services to support clients in the development, clinical and commercial supply of medicines globally.
-
The Latest Enhancements To Cryoport Express® Standard & Combo Cryogenic Shippers
5/20/2022
At Cryoport Systems, we are continuously striving to align with the latest science and technology advancements in our products and services, integrating the most advanced packaging, informatics, and logistics capabilities on the market today. Thus, we are pleased to share the official launch of our new Cryoport Express® Standard & Combo Cryogenic Shippers this month. The new models provide maximum protection of your valuable commodities with advanced, robust packaging and new feature enhancements. The new Cryoport Express® shippers are now available from our U.S. facilities and will soon become accessible out of our EMEA and APAC region facilities in the following months.